Skip to content

Taperloc Complete Primary Femoral 51-101170Recalls & reported problems

Biomet Orthopedics, LLC · Class 2 · Implant

All models of Taperloc Complete Primary Femoral (40)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00880304499157), received between Apr 6, 2023 and Apr 6, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Migration or Expulsion of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Migration or Expulsion of Device1

Patient problems

  • Failure of Implant1
  • Unequal Limb Length1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 6, 2023Migration or Expulsion of Device; Migration or Expulsion of Device

    THERE IS NO UPDATE TO THE PRIOR EVENT DESCRIPTION PROVIDED.

    Patient problems: Failure of Implant; Unequal Limb Length

    MAUDE report 16691684 ↗

Other Prosthesis, hip, semi-constrained, uncemented, metal / polymer, non-porous, calcium phosphate devices

All Prosthesis, hip, semi-constrained, uncemented, metal / polymer, non-porous, calcium phosphate devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page